For International Pharmaceutical and Biotechnology companies one or more of the following opportunities available from Australia and New Zealand, may be of interest in human medicine development collaborations / partnerships:

• Clinical stage compounds,
• Preclinical lead discovery/development projects,
• Outsourcing clinical trials, and
• Contract analytical services.

Clinical Stage

Clinical stage CNS / Neurology compounds.

Preclinical Stage

Oncology compounds in preclinical stages.

Bioactives from Temperate/Cool Zone Natural Sources

Private laboratory with solid background in identifying and profiling bioactive molecules derived from natural sources can offer:

• Bioactive compounds from unique protected indigenous New Zealand flora and fauna, obtained through official legally authorized access.
• Extensive research experience in lead compound discovery, focusing on natural sources not found elsewhere in the world.
• Access to diverse and unique protected indigenous flora and fauna sources which include microbes and invertebrates from Antarctica.
• Proprietary HTS / assay capabilities.

Bioactives from Tropical Natural Sources

Laboratory specializing in discovery and early stage development of small molecule bioactive lead compounds from tropical sources (including tropical rainforest plants and rainforest fungi) is seeking to partner with companies, at preclinical stage, that have the ability to further develop and, eventually, market products (e.g. oncology compounds) post-proof of concept.

Bioactives from Temperate/Cool Zone Marine Sources

• Marine species toxins showing activity in the areas of oncology and neuroscience.

Clinical Trials / Clinical Research Services

Clinical trial (phase I to IV studies) medical expertise and study / site management services are available in Australia and New Zealand:

• Oncology, Endocrinology, Urology, Neurology, Psychiatry, Respiratory and Cardiovascular pharmaceuticals and medical devices areas.
• Trials planned and managed to comply with requirements relevant to sponsor’s needs.
• Clinicians and local project managers have previously completed clinical trials meeting FDA and EU specifications.
• Experience in arranging local Ethics Committees certifications and Regulatory Authority approvals to trial unregistered formulations.

Bioanalytical Services

Accredited laboratory with experience and capabilities (LCMS systems) in the pharmaceutical area, offers analytical service for:

• Preclinical and clinical studies.
• Medical testing.
• Product development.
• Product comparison.
• Regulatory consultation.

Competitive cost advantages as well as timeliness of delivery and quality of the services provided, make Australia and New Zealand attractive options to consider.

For further information please contact:

Communications treated as confidential. Q1/10